How Young Workers Are Being Exploited in the COVID-19 Economy
Child labor is back. Why are more teens being exploited?
Read more...Child labor is back. Why are more teens being exploited?
Read more...FTI Consulting 2015 slides tout “discrediting” science, “debunking” documentaries, and hype its fracking industry project Energy In Depth
Read more...Another example of how the US health care system fails patients that could be treated.
Read more...Why big farms are often not better.
Read more...Many commodities, particularly metals and energy, are in short supply, which points to even higher prices.
Read more...Rents are up a lot in most places in the US of any consequence. Not all tenants are keeping pace.
Read more...James K. Galbraith discusses the shift of the US from industrialism to his so-called predator state: finance-led, military-centered corporatism
Read more...In How Novelty and Narratives Drive the Stock Market, economist Nicholas Mangee examines how stories influence stock market outcomes
Read more...Efforts to cure inflation, at least for poorer countries, will prove to be more damaging than the disease.
Read more...Occupy the SEC is back! The small group of lawyers, bank compliance experts, and financial services industry product specialists generated an outside reputation with its highly praised, over 300 page comment letter on Dodd Frank. As Law.com wrote: In detailing how they believe the Volcker Rule can be strengthened, Occupy the SEC has written what […]
Read more...A fresh report lead authored by Nathan Tankus takes on orthodoxy monetary policy ideas and provides Modern Monetary Theory solutions.
Read more...The IMF seems unable to drop its punitive, self and “client” destructive habits.
Read more...America has gone off the deep end re Ukraine. It’s pressuring allies to engage in economic self-harm, which is not a relationship-builder
Read more...The young are again on the forefront of change, now by challenging neoliberal atomization and indoctrination by forming unions.
Read more...regulators can step in to ensure drug pricing both supports patient access and drug development.
Read more...